PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 11, 2026PM&R0 citationsOpen Access

Hypovitaminosis D in acute inpatient cancer rehabilitation: Prevalence, predictors, and practical implications

View Full Paper
JTJegy M. TennisonMCMinxing ChenAHAreeba Hafeez

Key Points

  • This study aims to determine the prevalence of hypovitaminosis D in adults with cancer undergoing acute inpatient rehabilitation and identify relevant predictors.
  • Conducted a retrospective observational cohort study in an inpatient rehabilitation service at a tertiary cancer hospital.
  • Included consecutive adults with cancer admitted for acute rehabilitation between December 2023 and May 2024.
  • Evaluated vitamin D levels, demographic, clinical, and laboratory predictors, and the timing of vitamin D supplementation.
  • 62% (78 out of 126) patients had hypovitaminosis D upon admission.
  • Younger age (median 66.0 years) was a significant predictor of hypovitaminosis D (p = 0.006).
  • 40% of patients initiated vitamin D supplementation during rehabilitation, with 48% continuing at 3 months post-discharge.

Abstract

Abstract Background Hypovitaminosis D is associated with adverse health outcomes, including increased mortality in patients with cancer. Although vitamin D insufficiency (23%–72%) and deficiency (20%–71%) are common among patients admitted to inpatient rehabilitation, their prevalence and predictors in cancer‐specific inpatient rehabilitation populations remain uncharacterized. Objective To determine the prevalence of hypovitaminosis D in adults with cancer admitted to acute inpatient rehabilitation and to identify demographic, clinical, laboratory, and functional predictors. Design Retrospective observational cohort study. Setting An inpatient rehabilitation service within a tertiary cancer hospital. Patients Consecutive adults with a cancer diagnosis admitted for acute inpatient rehabilitation between December 1, 2023, and May 24, 2024. Interventions Not applicable. Main Outcome Measure(s) The primary outcome was the prevalence of hypovitaminosis D (25‐hydroxyvitamin D ≤ 29 ng/mL). Secondary outcomes included predictors of hypovitaminosis D and evaluation of the timing and frequency of vitamin D supplementation upon index hospital admission, upon admission to inpatient rehabilitation, and at 3 and 6 months post discharge. Results Of 126 patients, 78 (62%) had hypovitaminosis D. Significant predictors included relatively younger age (median 66.0 vs 71.5 years; effect size, 5.5 with 95% confidence interval CI, 1.60–9.40, p = .006) and presence of neurogenic bladder or bowel (16.7% vs 2.4%; odds ratio, 0.12 with 95% CI, 0.003–0.924, p = .019). At hospital admission, 29% ( n = 36) were receiving supplementation, and 40% ( n = 51) initiated supplementation during inpatient rehabilitation. At 3 and 6 months post discharge, 48% ( n = 61) and 39% ( n = 49), respectively, had records of continued supplementation. Vitamin D supplementation was generally well tolerated during inpatient rehabilitation, with only minor side effects that were managed in three patients. Conclusions Hypovitaminosis D was highly prevalent among adult patients with cancer undergoing inpatient rehabilitation. Identified predictors, including relatively younger age and neurogenic bladder or bowel, may help guide targeted screening.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Tennison et al. (2026) studied this question.

synapsesocial.com/papers/6a0171ed3a9f334c28271fb7https://doi.org/10.1002/pmrj.70151
Ask AI
Helpful
Bookmark
Share
View Full Paper